Russell Frank Company’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$10.6M Buy
1,565,963
+344,252
+28% +$2.27M 0.02% 909
2015
Q4
$9.82M Buy
1,221,711
+152,904
+14% +$1.12M 0.02% 898
2015
Q3
$6.13M Buy
1,068,807
+115,847
+12% +$717K 0.01% 1152
2015
Q2
$5.16M Buy
952,960
+155,599
+20% +$802K 0.01% 1396
2015
Q1
$3.72M Buy
797,361
+540,404
+210% +$2.35M 0.01% 1418
2014
Q4
$1.06M Buy
256,957
+107,269
+72% +$493K ﹤0.01% 2111
2014
Q3
$780K Buy
+149,688
New +$769K ﹤0.01% 2184
2013
Q4
Sell
-178
Closed -$1K 2952
2013
Q3
$1K Buy
+178
New +$502 ﹤0.01% 3397

Other funds holding NEO

Russell Frank Company's NEO Position: Q1 2016 in Review

Russell Frank Company increased its NeoGenomics (NEO) stake by 28% in Q1 2016, buying an estimated $2.27M and bringing the position to 1,565,963 shares worth $10.6M. The position accounts for 0.02% of the portfolio, ranked #909.

Russell Frank Company first reported a position in NEO in Q3 2013 and has held it in 8 quarters since. 119 funds tracked by Wall St. Rank hold NEO as of Q1 2016.

  • Russell Frank Company held 1,565,963 shares of NeoGenomics worth $10.6M as of Q1 2016.
  • Russell Frank Company bought 344,252 NeoGenomics shares in Q1 2016, an estimated $2.27M.
  • NeoGenomics made up 0.02% of Russell Frank Company's portfolio in Q1 2016, its #909 holding.
  • Russell Frank Company first reported a position in NeoGenomics in Q3 2013 and has held it in 8 quarters since.
  • 119 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.